A cancer diagnosis does not only attack the body – it disrupts a person’s entire psychological world. The uncertainty of outcomes, the loss of physical control, repeated hospital visits, and the looming question of mortality create a level of emotional distress that medical treatment alone cannot address. Studies estimate that between 30 and 50 percent of cancer patients experience clinically significant psychological distress at some point during their illness, with anxiety and depression being the most frequently reported conditions across all disease stages. This is why psychotherapy is no longer a secondary consideration in cancer care – it is an essential component of comprehensive treatment. Below, we explore the unique psychosocial challenges cancer creates and the therapeutic approaches that directly address them.
Table of Contents
- Why cancer creates unique psychological challenges
- Psychoeducational interventions
- Cognitive-behavioral therapy (CBT)
- How CBT is applied in oncology settings
- Supportive-expressive therapy
- Integrative approaches: combining cognitive, supportive, and existential elements
- Meaning-centered psychotherapy
- CALM therapy
- Cognitive-existential group therapy
- The case for psychotherapy as standard oncology care
Why cancer creates unique psychological challenges
Unlike many acute illnesses, cancer is typically prolonged, unpredictable, and punctuated by cycles of treatment, waiting, and uncertainty. Patients must cope with multiple stressors spanning diagnosis, surgery, chemotherapy, radiation, and survivorship – each phase bringing its own emotional demands. The fear of disease progression or recurrence is one of the most persistent concerns; even anxiety about routine cancer surveillance scans – sometimes called “scanxiety” – is common and significantly worsens quality of life.
Loss of control is another defining feature of the cancer experience. Patients frequently shift from seeing themselves as healthy individuals to managing a reality of ongoing illness, which can produce a profound sense of helplessness. Anxiety and depression in cancer patients are associated with poor quality of life, increased physical symptoms such as pain and nausea, poorer adherence to treatment, and higher mortality risk. Addressing these psychological dimensions is not optional – it is clinically necessary.
Psychoeducational interventions
One of the first lines of psychological support for cancer patients is psychoeducation. This involves providing patients and their families with structured information about the diagnosis, treatment process, potential side effects, and coping strategies. The goal is straightforward: knowledge reduces fear. When patients understand what is happening to their bodies and what to expect from treatment, the unknown becomes less threatening.
Psychoeducation empowers patients with the knowledge and tools needed to manage their psychological and emotional responses, enhancing self-efficacy and mental health. It also directly targets the helplessness many patients feel by restoring a sense of agency – the understanding that there are things they can actively do and anticipate. Clinical guidelines from the American Society of Clinical Oncology recommend that all oncology patients be offered education regarding depression and anxiety as a baseline standard of care. Beyond individual patients, psychoeducation can also be extended to family members, equipping them to provide more informed and responsive support.
Cognitive-behavioral therapy (CBT)
Cognitive-behavioral therapy operates on the core principle that thoughts and behaviors significantly influence feelings. For cancer patients, this is particularly relevant. Distressing thoughts – such as “I won’t survive this” or “I am a burden to everyone around me” – can feed cycles of hopelessness, withdrawal, and worsening mood. CBT intervenes by teaching patients to identify these unhelpful thought patterns, evaluate their accuracy, and replace them with more balanced perspectives.
How CBT is applied in oncology settings
In cancer care, CBT typically incorporates several practical techniques. Cognitive restructuring, relaxation training, skills training, and visual imagery are among the most commonly used CBT components for this population. Behavioral activation encourages patients to engage in meaningful activities even when motivation is low, which helps counter depressive withdrawal. Relaxation techniques such as deep breathing and progressive muscle relaxation equip patients with immediate tools for managing anxiety and physical tension.
A meta-analysis of 13 randomized controlled trials demonstrated that CBT has a significant effect on improving psychological resilience in cancer patients, helping them build stronger adaptive coping mechanisms. CBT can be delivered in individual sessions, group formats, or even through digital platforms, making it one of the most adaptable therapeutic tools available in oncology. Group CBT in particular provides emotional support and helps patients alleviate isolation through shared experiences, which is especially valuable given how socially isolating cancer can be.
It is worth noting that CBT is not a one-size-fits-all intervention. Experienced clinicians often recommend beginning with purely supportive, validating contact at the point of diagnosis before introducing structured CBT techniques, as patients first need to feel heard before engaging in cognitive work.
Supportive-expressive therapy
Supportive-expressive therapy (SET) takes a different approach from CBT. Rather than restructuring thought patterns, it prioritizes emotional openness – creating a safe, supported environment where patients can articulate their fears, grief, anger, and anxiety without judgment. Derived conceptually from existential psychotherapy, supportive-expressive group therapy has been widely tested in breast cancer and has strong evidence for its efficacy in improving mood, relieving traumatic stress, and enhancing quality of life.
The therapy’s goals include fostering mutual support, encouraging emotional expression, improving family and social bonds, helping patients integrate cancer into their self-image, and addressing death and dying directly rather than avoiding the topic. Supportive-expressive group therapy has been found to benefit mood, coping, and traumatic stress symptoms particularly among women with metastatic breast cancer. For many patients, simply being in a group where others understand their experience – without the need to protect family members from distress – is deeply therapeutic in itself.
Integrative approaches: combining cognitive, supportive, and existential elements
Many patients dealing with advanced cancer require more than symptom management – they face genuinely existential questions about identity, legacy, purpose, and mortality. Integrative approaches attempt to combine cognitive, supportive, and existential frameworks into cohesive therapeutic models.
Meaning-centered psychotherapy
Developed by Dr. William Breitbart and colleagues at Memorial Sloan Kettering Cancer Center, meaning-centered psychotherapy (MCP) was specifically designed for patients with advanced cancer. MCP aims to increase patients’ sense of meaning and spiritual well-being by bringing awareness to their attitudes, their ability to connect and engage with life, and the legacy they have created or wish to create. Therapists help patients explore questions of purpose directly, including openly addressing death anxiety – a process sometimes referred to as “detoxifying death.”
A large randomized controlled trial of individual meaning-centered psychotherapy found significant improvements in quality of life, sense of meaning, spiritual well-being, and anxiety in patients with advanced cancer compared to those receiving usual care. Research has also found that MCP outperforms CBT specifically in increasing presence of meaning in life, purpose, and life goals – outcomes that CBT is not primarily designed to achieve.
CALM therapy
Managing Cancer and Living Meaningfully (CALM) is another integrative model developed for patients with advanced disease. CALM therapy draws on relational theory, attachment theory, and existential theory to help patients manage both the practical challenges of living with advanced cancer and the psychological preparation for end of life. It addresses symptom management, changes in relationships, spirituality, and mortality in a structured but flexible format.
CALM has shown particular promise in reducing depressive symptoms and improving attachment security, making it a vital intervention for patients with advanced cancer. Its strength lies in its breadth – it does not focus on one domain but attends simultaneously to emotional, relational, and existential concerns.
Cognitive-existential group therapy
Cognitive-existential group therapy blends elements of CBT with existential therapy, making it especially suited to patients grappling with both distorted thought patterns and deeper questions about identity and meaning. Integrating mindfulness with cognitive-behavioral strategies has shown promise in enhancing psychological flexibility, which is crucial for coping with the uncertainties associated with cancer. This combination targets immediate psychological symptoms while also building the long-term resilience needed to live well with illness.
The case for psychotherapy as standard oncology care
Collectively, the evidence for psychotherapy in cancer care is substantial. A systematic review and meta-analysis of randomized clinical trials found that psychological interventions significantly improved quality of life in patients with early-stage cancer, suggesting that psychotherapy should be introduced as standard care for all cancer patients. Clinical practice guidelines from the European Society for Medical Oncology support psychoeducation, CBT, mindfulness-based therapies, and supportive-expressive therapies as evidence-based treatments for anxiety and depression in oncology settings.
What this means practically is that no single therapeutic approach fits every patient or every stage of illness. A newly diagnosed patient may benefit most from psychoeducation and supportive validation. A patient undergoing active treatment may gain most from CBT’s coping skills. A patient with advanced disease may need the existential depth offered by MCP or CALM. The skill of a good oncology therapist lies in reading where the patient is and matching the intervention accordingly – and in being willing to draw on multiple frameworks when needed.
What do you think? As cancer treatments continue to improve and more people live longer with the disease, how should healthcare systems adapt to ensure psychological care is consistently available – not as an afterthought, but as a core part of oncology? And when a patient’s needs span emotional, cognitive, and existential dimensions all at once, how should therapists decide which framework to prioritize?
References
- https://ascopubs.org/doi/10.1200/JCO.23.00293
- https://pmc.ncbi.nlm.nih.gov/articles/PMC10358426/
- https://www.esmoopen.com/article/S2059-7029(23)00375-7/fulltext
- https://pmc.ncbi.nlm.nih.gov/articles/PMC11857804/
- https://www.targetedonc.com/view/cbt-benefits-cancer-patients-mental-health-treatment-adherence
- https://pmc.ncbi.nlm.nih.gov/articles/PMC4577033/
- https://bmcpsychiatry.biomedcentral.com/articles/10.1186/s12888-025-06628-3
- https://onlinelibrary.wiley.com/doi/10.1002/9780470975176.ch10
- https://psychiatryonline.org/doi/10.1176/appi.psychotherapy.20190050
- https://pmc.ncbi.nlm.nih.gov/articles/PMC4861219/
- https://pubmed.ncbi.nlm.nih.gov/29757459/
- https://www.sciencedirect.com/science/article/pii/S0005789424000418
- https://www.nature.com/articles/s41598-024-63431-y
Leave a Reply